Galactic

Idiopathic Pulmonary Fibrosis Study

Main objective:

In this study, an inhaled investigational is taken at daily over 52 weeks to evaluate the efficacy and safety, in participants who have Idiopathic Pulmonary Fibrosis.

Who are we looking for?

  • Established diagnosis of Idiopathic Pulmonary Fibrosis
  • Age: 40+
  • Additional criteria not listed here

What’s provided for duration of study:

  • Study medication
  • Safety testing
  • Modest payments for each visit completed

If you would like additional information, please send us an email or give us a call!

Call: 334-699-1631

Thank you for your interest – we look forward to hearing from you!